title: [TLV exceeds it mandate in its drug survey].
authors: lars.linnersten@skane.se
authors: Lars
authors: L
authors: Linnersten
mesh_terms: D000928:Antidepressive Agents / Q000191:economics*; D016265:Conflict of Interest; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics*; D013548:Sweden
chemical_list: D000928:Antidepressive Agents; D016568:Drugs, Generic; D017367:Selective Serotonin Reuptake Inhibitors